tirzepatide vs semaglutide compounded Tirzepatide: Which Is Right? I had gained 35 pounds

In SURMOUNT-1, which enrolled 2,539 adults with obesity, participants received tirzepatide at 5 mg, 10 mg, or 15 mg once weekly for 72 weeks

Multiply that volume by your concentration to confirm you are getting 7.5 mg

Changes in waist circumference and cardiometabolic parameters are shown in Table 5

SURMOUNT-1 results In this 72-week obesity trial, participants receiving tirzepatide achieved remarkable weight loss results: 5 mg dose: 85% achieved at least 5% weight reduction, with average weight loss of 15% 10 mg dose: 89% achieved at least 5% weight reduction, with average weight loss of 19% 15 mg dose: 91% achieved at least 5% weight reduction, with average weight loss of 21% These results were achieved with consistent weekly dosing

By targeting two pathways, tirzepatide improves insulin sensitivity and promotes a greater feeling of fullness, leading to significant and sustained weight loss for many people